| 产品详情 |
| Edit |   |
| Antigenic Specificity | CD19 & CD22 |
| Clone | n/a |
| Host Species | Recombinant Human/Human |
| Reactive Species | human |
| Isotype | n/a |
| Format | bispecific |
| Size | n/a |
| Concentration | n/a |
| Applications | FuncS; Promising therapeutic agent |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Recombinant Anti-CD19 x Anti-CD22 Bispecific Antibody (IgG-scFv) is designed to be expressed as a LC and an extended HC with scFv moiety linked to the C terminus. It is a symmetric bispecific and tetravalent molecule, bivalent for each antigen specificity, 2+2 antigen-binding valency. This BsAb is designed for the research of B cell lymphoma; Leukemia therapy. |
| Immunogen | n/a |
| Other Names | BsAb |
| Gene, Accession # | n/a |
| Catalog # | IGFV-039 |
| Price | |
| Order / More Info | CD19 & CD22 Antibody from CREATIVE BIOLABS |
| Product Specific References | n/a |
| 产品资料 |
|
|